Dispatch

UNFPA donates Misoprostol to save lives of mothers

19 November 2015

UNFPA has handed over a donation of Misoprostol medicines to support the Ministry of Health of Rwanda through Rwanda Biomedical Center (RBC) to save lives of women in Rwanda. 
Misoprostol is a strong lifesaving uterotonic medicine which by enhancing uterine retraction/contraction reduces post-partum hemorrhage which is a common complication that mothers face after giving birth and sometimes leads to death.

UNFPA has handed over a donation of Misoprostol medicines to support the Ministry of Health of Rwanda through Rwanda Biomedical Center (RBC) to save lives of women in Rwanda.

 

 

 

 

 

 

 

 

 

Misoprostol is a strong lifesaving uterotonic medicine which by enhancing uterine retraction/contraction reduces post-partum hemorrhage which is a common complication that mothers face after giving birth and sometimes leads to death.

Misoprostol has efficacy rates of 91% to 99%, which are comparable to the efficacy rates of surgical evacuation procedures for evacuation of the uterus.

The use of Misoprostol particularly for women who give birth at home or in facilities that lack basic supplies, medicines, and infrastructure offer an unprecedented opportunity for countries to improve maternal health.

The recent Confidential Enquiry into Maternal Deaths national survey reported post-partum hemorrhage as the leading cause of maternal mortality with 43.9% in Rwanda. However, the use of Misoprostol has contributed to the drastic reduction of maternal mortality ratio from 487 per 100,000 live births (2010) to 210 per 100,000 live births (2015).

The UNFPA Representative explained that evidence has shown that Misoprostol can prevent excessive bleeding and reduce bleeding after it has started. Therefore partners need to work together to ensure that every community and every woman has access to Misoprostol for preventing and treating postpartum hemorrhage.

Olivier Ngenzi, a representative from Maternal Child and Community Health Division at Rwanda Biomedical Centeracknowledged the donation and commended UNFPA's continuous support in health sector.

"We have always had a fruitful collaboration between RBC and UNFPA which we are grateful for. This medicine in particular is a great support to saving lives of women after giving birth" Olivier said on behalf of RBC

The UNFPA Representative reaffirms commitment to support the country to improve health status of the population with a particular focus on maternal health, family planning, HIV prevention and young people.

The donation is one of the items provided under the Global Programme to enhance Reproductive Health Commodity Security, currently known as UNFPA supplies.